10
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Open Field Behavior in Nucleus Basalis Magnocellularis-Lesioned Rats Treated with Physostigmine and Verapamil

, , , , &
Pages 181-188 | Received 01 May 1997, Published online: 07 Jul 2009

References

  • Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408–417
  • Bergman-Evans B. F. Alzheimer's and related disorders: loneliness, depression, social support of spousal caregivers. Journal of Gerontology Nurseling 1994; 20: 6–16
  • Connor D. J., Langlais P. J., Thai L. J. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Research 1991; 555: 84–90
  • Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184–1190
  • Czyrak A., Mogilnicka E., Siwanowicz J., Maj J. Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacology, Biochemistry and Behavior 1990; 35: 557–560
  • Dokla C. P. J., Thai L. J. Effect of cholinesterase inhibitors on Morris water maze task behavior following lesions of nucleus basalis magnocellularis. Behavioral Neuroscience 1988; 102: 861–871
  • Engel J. A., Fahlke C., Hulthe P., Hard E., Johannessen K., Snape B., Svennson L. Biochemical and behavioral evidence for an interaction between ethanol and calcium channel antagonists. Journal of Neural Transmission 1988; 74: 181–193
  • Fisher A., Brandeis R., Karton I., Pittel Z., Gurwitz D., Huring R., Sapir M., Levy A., Heldman E. ()-cis-2-methyl-spiro(1,3-oxathiolane-5-3′> quinuclidine, an Ml selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 1991; 257: 392–403
  • Gower A. J., Rousseau D., Jasmin P., Gobert J., Hanin I., Wulfert E. Behavioral and histological effects of low concentrations of intraventricular AF64A. European Journal of Pharmacology 1989; 166: 271–281
  • Haroutunian V., Kanof P., Davis K. L. Pharmacological alleviation of cholinergic lesion induced memory deficits in rats. Life Sciences 1985; 37: 945–952
  • Hall C. S. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. Journal of Comparative Physiological Psychology 1934; 18: 385–403
  • Huston J. P., Bure J. Innate and motivated behavior—2.5 Open field. Techniques and basic experiments for the study of brain and behavior, Chapter 2, J. Bure, O. J.P. Bureova, J. P. Huston. Elsevier Science Publishers B.V, Amsterdam, New York 1983; 95–97
  • Kromer Vogt L. J., Hyman B. T., Van Hoesen G. W., Damasio A. R. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 1990; 37: P377–385
  • Liu W.-F., Hu N.-W., Chien T.-F., Beaton J. M. Effects of 3-quinuclidinyl benzilate on fixed-ratio responding and open field behavior in the rat. Psychopharmacology 1983; 80: 10–13
  • Mandel R. J., Thai L. J. Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats. Psychopharmacology 1988; 96: 421–425
  • Ogishima M., Hiraga Y., Washizuka M., Kobayashi N., Nakata N., Ikeda Y. Differential effects of intracerebroventricular AF64A injection, nucleus basalis of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats. Yakubutsu Seishin Kodo 1992; 12: 85–92
  • Paxinos G., Watson C. The rat brain in stereotaxic coordinates. Academic Press, Sydney 1982
  • Popovi M., Jovanova-Nei K., Bokonji D., Dobri S., Popovi N., Rosi N. Effect of verapamil on spontaneous motor activity and two-way avoidance learning in nucleus basalis-lesioned rats. European Journal of Neuroscience 1995; 171, Suppl. 8
  • Popovi M., Jovanova-Nei K., Popovi N., Bokonji D., Dobri S., Rosi N., Raki Lj. Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats. International Journal of Neuroscience 1996; 86: 281–299
  • Popovi M., Popovi N., Jovanova-Nei K., Bokonji D., Dobri S., Kosti V. S., Rosi N. Effect of physostigmine and verapamil on active avoidance in an experimental model of Alzheimer's disease. International Journal of Neuroscience., (in press)
  • Rezvani A. H., Mack C. M., De Lacy P. A., Janowsky D. S. Verapamil effects on physiological and behavioral responses to ethanol in the rat. Alcohol and Alcoholism 1990; 25: 51–58
  • Rogerio R., Takahashi R. N. Some calcium channel antagonists have no effect on the open-field behavior of rats nor do they interact with cocaine. Brazilian Journal of Medical and Biological Research 1990; 23: 1153–1155
  • Santucci A. C., Kanof P. D., Haroutunian V. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Psychopharmacology 1989; 99: 70–74
  • Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Research Review 1988; 13: 103–118
  • Stewart W. J., Blain S. Dose-response effects of scopolamine on activity in an open field. Psychopharmacology 1975; 44: 291–295
  • Stodulka J. Ethanol and physostigmine effects on open field behavior in Wistar rats. Acta Universitatis Palackianae Olomucensis Facultalis Medical 1991; 131: 39–81
  • Stone W. S., Rudd R. J., Gold P. E. Glucose and physostigmine effects on morphine- and amphetamine-induced increases in locomotor activity in mice. Behavioral and Neural Biology 1990; 54: 146–155
  • Vereecken T. H., Vogels O. J., Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiology of Aging 1994; 15: 45–54
  • Waite J. J., Thai L. J. The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis. Neuroscience Research 1995; 21: 251–259
  • Yamazaki N., Kato K., Kurihara E., Nagaoka A. Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats. Psychopharmucology 1991; 103: 215–222

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.